IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Harpoon Therapeutics Inc

CUSIP: 41358P906 | 3 institutional holders

Quarters

Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022
CompareDetailedHistoricalFundsOptionsShort Interest13D/13GPeersTargetingTrading SummaryProfile